Form D — Indaptus Therapeutics, Inc.
0001641172-25-015841 · filed 2025-06-20
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06c
- Total offering
- $5,000,000
- Total sold
- $2,314,800
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Indaptus Therapeutics, Inc.
- CIK
- 1857044
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 3 COLUMBUS CIRCLE
NEW YORK, NY 10019 - Phone
- (646) 427-2727
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jeffrey A. Meckler · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Michael J Newman · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Nir Sassi · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Walt A. Linscott · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Roger J. Waltzman · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Roger J. Pomerantz · DirectorNew York, NY Find on LinkedIn ↗
-
Hila Karah · DirectorNew York, NY Find on LinkedIn ↗
-
Anthony J. Maddaluna · DirectorNew York, NY Find on LinkedIn ↗
-
William B. Hayes · DirectorNew York, NY Find on LinkedIn ↗
-
Mark J. Gilbert · DirectorNew York, NY Find on LinkedIn ↗
-
Robert E. Martell · DirectorNew York, NY Find on LinkedIn ↗
View original on SEC EDGAR.